IL33 and kidney disorder: Although ILC2s account for approximately 1% of total renal leukocytes, IL-33 expression is upregulated in several kidney disease models, indicating that renal ILC2s are potentially activated and exert unknown functions at both the acute and chronic phases (Figure 1).